Dr Kevin Blyth

  • Honorary Professor (Institute of Cancer Sciences)

email: Kevin.Blyth@glasgow.ac.uk

Room 340, School of Medicine, Wolfson Medical Building, G12 8qq

ORCID iDhttps://orcid.org/0000-0003-2972-6641

Biography


Kevin Blyth is Professor of Respiratory Medicine in Glasgow.

Following completion of Internal and Respiratory Medicine training and the award of an MD in Magnetic Resonance Imaging he was appointed as a Consultant in 2009.

He splits his time between the CRUK Beatson Institute/University of Glasgow and the Queen Elizabeth University Hospital, where he leads the Glasgow Pleural Disease Unit.

He founded and is Director of the Macmillan Scottish Mesothelioma Network, which coordinates clinical care and access to clinical trials for Mesothelioma patients in Scotland.

He is an NHS Scotland Research (NRS) Senior Research Fellow and leads a translational research program focused on pleural disease and thoracic malignancy, and has a particular interest in Mesothelioma.

He is Principal Investigator of the CRUK PREDICT-Meso International Accelerator Network.


 

Publications

List by: Type | Date

Jump to: 2020 | 2019 | 2018 | 2017 | 2016 | 2015
Number of items: 21.

2020

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1)

Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)

Ferguson, K., Quail, N., Kewin, P. and Blyth, K. G. (2020) COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Reports, 13(8), e237460. (doi: 10.1136/bcr-2020-237460) (PMID:32747597) (PMCID:PMC7401579)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (Early Online Publication)

AbdulJabbar, K. et al. (2020) Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nature Medicine, 26(7), pp. 1054-1062. (doi: 10.1038/s41591-020-0900-x) (PMID:32461698)

Litchfield, K. et al. (2020) Representative sequencing: unbiased sampling of solid tumor tissue. Cell Reports, 31(5), 107550. (doi: 10.1016/j.celrep.2020.107550) (PMID:32375028)

2019

Cunningham, Y., Wyke, S. , Blyth, K. G. , Rigg, D., Macdonald, S. , Macleod, U., Harrow, S., Robb, K. A. and Whitaker, K. L. (2019) Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: a qualitative interview study. Psycho-Oncology, 28(4), pp. 718-725. (doi: 10.1002/pon.5005) (PMID:30693608) (PMCID:PMC6492269)

2018

Lindsay, C. R. et al. (2018) Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. ESMO Open, 3(6), e000408. (doi: 10.1136/esmoopen-2018-000408) (PMID:30233821) (PMCID:PMC6135448)

Martin, G. A. , Tsim, S., Kidd, A. C., Foster, J. E., McLoone, P., Chalmers, A. and Blyth, K. G. (2018) Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion. BMJ Open Respiratory Research, 5(1), e000293. (doi: 10.1136/bmjresp-2018-000293) (PMID:29862030) (PMCID:PMC5976095)

Tsim, S. et al. (2018) Early Contrast Enhancement: a novel Magnetic Resonance Imaging biomarker of pleural malignancy. Lung Cancer, 118, pp. 48-56. (doi: 10.1016/j.lungcan.2018.01.014)

Blyth, K. G. and Murphy, D. J. (2018) Progress and challenges in Mesothelioma: from bench to bedside. Respiratory Medicine, 134, pp. 31-41. (doi: 10.1016/j.rmed.2017.11.015)

Cherrie, J. W., McElvenny, D. and Blyth, K. G. (2018) Estimating past inhalation exposure to asbestos: a tool for risk attribution and disease screening. International Journal of Hygiene and Environmental Health, 221(1), pp. 27-32. (doi: 10.1016/j.ijheh.2017.09.013) (PMID:29030093)

Haughney, J., Morice, A., Blyth, K. G. , Lee, A. J., Coutts, A., McKnight, E. and Pavord, I. (2018) A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels. Respiratory Medicine, 134, pp. 117-123. (doi: 10.1016/j.rmed.2017.12.001) (PMID:29413497)

Kidd, A. C., McGettrick, M., Tsim, S., Halligan, D. L., Bylesjo, M. and Blyth, K. G. (2018) Survival prediction in mesothelioma using a scalable lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respiratory Research, 5(1), e000240. (doi: 10.1136/bmjresp-2017-000240) (PMID:29468073) (PMCID:PMC5812388)

Sharma, V. and Blyth, K. G. (2018) Empyema necessitans and a persistent air leak associated with rupture of an anaerobic lung abscess due to bacteroides. Thorax, 73(1), pp. 91-93. (doi: 10.1136/thoraxjnl-2017-210462) (PMID:28847872)

2017

Murphy, D. J. and Blyth, K. G. (2017) Predicting lung cancer recurrence from circulating tumour DNA. Commentary on 'Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution'. Cell Death and Differentiation, 24(9), pp. 1473-1474. (doi: 10.1038/cdd.2017.97) (PMID:28622291)

Blyth, K. G. , Bellofiore, A., Jayasekera, G., Foster, J. E., Steedman, T., Chesler, N. C. and Peacock, A. J. (2017) Dobutamine stress MRI in pulmonary hypertension: relationships between stress pulmonary artery relative area change, RV performance, and 10-year survival. Pulmonary Circulation, 7(2), pp. 465-475. (doi: 10.1177/2045893217704838) (PMID:28597775) (PMCID:PMC5467938)

Tsim, S., Stobo, D. B., Alexander, L., Kelly, C. and Blyth, K. G. (2017) The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy. Lung Cancer, 103, pp. 38-43. (doi: 10.1016/j.lungcan.2016.11.010) (PMID:28024694) (PMCID:PMC5226066)

2016

Tsim, S. et al. (2016) Diagnostic and prognostic biomarkers in the rational assessment of mesothelioma (DIAPHRAGM) study: protocol of a prospective, multi-centre, observational study. BMJ Open, 6(11), e013324. (doi: 10.1136/bmjopen-2016-013324) (PMID:27884852) (PMCID:PMC5168514)

Armato, S. G., Blyth, K. G. , Keating, J. J., Katz, S., Tsim, S., Coolen, J., Gudmundsson, E., Opitz, I. and Nowak, A. K. (2016) Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group. 2016 International Conference of the International Mesothelioma Interest Group (iMig), Birmingham, UK, 01-04 May 2016. pp. 48-58. (doi:10.1016/j.lungcan.2016.09.003)

2015

Blyth, K. G. (2015) Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies. Thorax, 70(4), p. 374. (doi: 10.1136/thoraxjnl-2014-206464) (PMID:25480442)

This list was generated on Fri Nov 27 13:28:27 2020 GMT.
Number of items: 21.

Articles

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1)

Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)

Ferguson, K., Quail, N., Kewin, P. and Blyth, K. G. (2020) COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Reports, 13(8), e237460. (doi: 10.1136/bcr-2020-237460) (PMID:32747597) (PMCID:PMC7401579)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (Early Online Publication)

AbdulJabbar, K. et al. (2020) Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nature Medicine, 26(7), pp. 1054-1062. (doi: 10.1038/s41591-020-0900-x) (PMID:32461698)

Litchfield, K. et al. (2020) Representative sequencing: unbiased sampling of solid tumor tissue. Cell Reports, 31(5), 107550. (doi: 10.1016/j.celrep.2020.107550) (PMID:32375028)

Cunningham, Y., Wyke, S. , Blyth, K. G. , Rigg, D., Macdonald, S. , Macleod, U., Harrow, S., Robb, K. A. and Whitaker, K. L. (2019) Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: a qualitative interview study. Psycho-Oncology, 28(4), pp. 718-725. (doi: 10.1002/pon.5005) (PMID:30693608) (PMCID:PMC6492269)

Lindsay, C. R. et al. (2018) Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. ESMO Open, 3(6), e000408. (doi: 10.1136/esmoopen-2018-000408) (PMID:30233821) (PMCID:PMC6135448)

Martin, G. A. , Tsim, S., Kidd, A. C., Foster, J. E., McLoone, P., Chalmers, A. and Blyth, K. G. (2018) Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion. BMJ Open Respiratory Research, 5(1), e000293. (doi: 10.1136/bmjresp-2018-000293) (PMID:29862030) (PMCID:PMC5976095)

Tsim, S. et al. (2018) Early Contrast Enhancement: a novel Magnetic Resonance Imaging biomarker of pleural malignancy. Lung Cancer, 118, pp. 48-56. (doi: 10.1016/j.lungcan.2018.01.014)

Blyth, K. G. and Murphy, D. J. (2018) Progress and challenges in Mesothelioma: from bench to bedside. Respiratory Medicine, 134, pp. 31-41. (doi: 10.1016/j.rmed.2017.11.015)

Cherrie, J. W., McElvenny, D. and Blyth, K. G. (2018) Estimating past inhalation exposure to asbestos: a tool for risk attribution and disease screening. International Journal of Hygiene and Environmental Health, 221(1), pp. 27-32. (doi: 10.1016/j.ijheh.2017.09.013) (PMID:29030093)

Haughney, J., Morice, A., Blyth, K. G. , Lee, A. J., Coutts, A., McKnight, E. and Pavord, I. (2018) A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels. Respiratory Medicine, 134, pp. 117-123. (doi: 10.1016/j.rmed.2017.12.001) (PMID:29413497)

Kidd, A. C., McGettrick, M., Tsim, S., Halligan, D. L., Bylesjo, M. and Blyth, K. G. (2018) Survival prediction in mesothelioma using a scalable lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respiratory Research, 5(1), e000240. (doi: 10.1136/bmjresp-2017-000240) (PMID:29468073) (PMCID:PMC5812388)

Sharma, V. and Blyth, K. G. (2018) Empyema necessitans and a persistent air leak associated with rupture of an anaerobic lung abscess due to bacteroides. Thorax, 73(1), pp. 91-93. (doi: 10.1136/thoraxjnl-2017-210462) (PMID:28847872)

Murphy, D. J. and Blyth, K. G. (2017) Predicting lung cancer recurrence from circulating tumour DNA. Commentary on 'Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution'. Cell Death and Differentiation, 24(9), pp. 1473-1474. (doi: 10.1038/cdd.2017.97) (PMID:28622291)

Blyth, K. G. , Bellofiore, A., Jayasekera, G., Foster, J. E., Steedman, T., Chesler, N. C. and Peacock, A. J. (2017) Dobutamine stress MRI in pulmonary hypertension: relationships between stress pulmonary artery relative area change, RV performance, and 10-year survival. Pulmonary Circulation, 7(2), pp. 465-475. (doi: 10.1177/2045893217704838) (PMID:28597775) (PMCID:PMC5467938)

Tsim, S., Stobo, D. B., Alexander, L., Kelly, C. and Blyth, K. G. (2017) The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy. Lung Cancer, 103, pp. 38-43. (doi: 10.1016/j.lungcan.2016.11.010) (PMID:28024694) (PMCID:PMC5226066)

Tsim, S. et al. (2016) Diagnostic and prognostic biomarkers in the rational assessment of mesothelioma (DIAPHRAGM) study: protocol of a prospective, multi-centre, observational study. BMJ Open, 6(11), e013324. (doi: 10.1136/bmjopen-2016-013324) (PMID:27884852) (PMCID:PMC5168514)

Blyth, K. G. (2015) Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies. Thorax, 70(4), p. 374. (doi: 10.1136/thoraxjnl-2014-206464) (PMID:25480442)

Conference or Workshop Item

Armato, S. G., Blyth, K. G. , Keating, J. J., Katz, S., Tsim, S., Coolen, J., Gudmundsson, E., Opitz, I. and Nowak, A. K. (2016) Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group. 2016 International Conference of the International Mesothelioma Interest Group (iMig), Birmingham, UK, 01-04 May 2016. pp. 48-58. (doi:10.1016/j.lungcan.2016.09.003)

This list was generated on Fri Nov 27 13:28:27 2020 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • PREDICT-Meso: PRE-malignant Drivers Combined with Target-Drug validation in Mesothelioma
    Cancer Research UK
    2020 - 2021
     
  • STRATIFY : Staging by Thoracoscopy in potentially Radically Treatable Non-Small Cell Lung Cancer associated with Minimal Pleural Effusion
    Chief Scientist Office
    2018 - 2021
     
  • DIAPHRAGM Fibulin-3 Analysis
    NHS Greater Glasgow and Clyde Endowment Funds
    2018 - 2020
     
  • DIAPHRAGM Sample Analysis
    NHS Greater Glasgow and Clyde
    2018 - 2020
     
  • Meso-ORIGINS Feasibility Study
    June Hancock Mesothelioma Research Fund
    2018 - 2019
     
  • BCC funded half of TRACERx fellow-K Blyth
    Beatson Institute for Cancer Research
    2017 - 2018
     
  • CRUK TRACERx Lung Cancer Fellow
    Cancer Research UK
    2017 - 2018
     
  • PRISM - Prediction of Resistance to chemotherapy using Somatic Copy Number Variation in Mesothelioma
    British Lung Foundation
    2017 - 2020
     
  • DIAPHRAGM Sample Analysis
    NHS Greater Glasgow and Clyde Endowment Funds
    2015 - 2018
     
  • An examination of diagnostic and prognostic biomarkers in malignant pleural mesothelioma
    Chief Scientist Office
    2013 - 2018
     

Supervision